PTO- 1581 |
Approved for use through 03/31/2024. OMB 0651-0054 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Input Field |
Entered |
SERIAL NUMBER | 88821077 |
---|---|
LAW OFFICE ASSIGNED | LAW OFFICE 115 |
MARK SECTION | |
MARK | AMAZE (see, http://uspto.report/TM/88821077/mark.png) |
STANDARD CHARACTERS | YES |
USPTO-GENERATED IMAGE | YES |
LITERAL ELEMENT | AMAZE |
OWNER SECTION (current) | |
NAME | LEO Pharma A/S |
MAILING ADDRESS | Industriparken 55 |
CITY | Ballerup |
ZIP/POSTAL CODE | 2750 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | Denmark |
XXXX | |
OWNER SECTION (proposed) | |
NAME | LEO Pharma A/S |
MAILING ADDRESS | Industriparken 55 |
CITY | Ballerup |
ZIP/POSTAL CODE | 2750 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | Denmark |
XXXX | |
CORRESPONDENCE INFORMATION (current) | |
NAME | B. Brett Heavner |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | docketing@finnegan.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | b.brett.heavner@finnegan.com; Jennifer.Coles@finnegan.comm |
DOCKET/REFERENCE NUMBER | 14894.53 |
CORRESPONDENCE INFORMATION (proposed) | |
NAME | B. Brett Heavner |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | docketing@finnegan.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | b.brett.heavner@finnegan.com; Jennifer.Coles@finnegan.comm |
DOCKET/REFERENCE NUMBER | 14894.53 |
GOODS AND/OR SERVICES SECTION | |
INTERNATIONAL CLASS | 005 |
CURRENT IDENTIFICATION | Pharmaceutical and medical preparations for treatment of skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and for treatment of the skin |
GOODS OR SERVICES | KEEP ALL LISTED |
INTERNATIONAL CLASS | 038 |
CURRENT IDENTIFICATION | Providing online forums for users for the sharing and transmission of information and messages about skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and in relation to treatment of the skin |
GOODS OR SERVICES | KEEP ALL LISTED |
INTERNATIONAL CLASS | 042 |
CURRENT IDENTIFICATION | Scientific and medical research in the field of skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and in relation to treatment of the skin; Pharmaceutical and scientific research and development services, scientific research and testing of pharmaceuticals, all in the field of skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and in relation to treatment of the skin; providing information and consulting services in the field of scientific and pharmaceutical research and development services and scientific research in relation to skin diseases and treatment of the skin; testing of pharmaceuticals in the field of skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and in relation to treatment of the skin |
GOODS OR SERVICES | KEEP ALL LISTED |
INTERNATIONAL CLASS | 044 |
CURRENT IDENTIFICATION | Medical services in the field of skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and in relation to treatment of the skin; medical and pharmaceutical consultation services and health consultation services, all in the field of skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and in relation to treatment of the skin |
GOODS OR SERVICES | KEEP ALL LISTED |
EXTENSION SECTION | |
EXTENSION NUMBER | 1 |
ALLOWANCE MAIL DATE | 11/10/2020 |
STATEMENT OF USE | NO |
PAYMENT SECTION | |
NUMBER OF CLASSES | 4 |
SUBTOTAL AMOUNT [EXTENSION FEE] | 500 |
TOTAL AMOUNT | 500 |
SIGNATURE SECTION | |
SIGNATURE | /B. Brett Heavner/ |
SIGNATORY'S NAME | B. Brett Heavner |
SIGNATORY'S POSITION | Attorney of Record |
DATE SIGNED | 05/06/2021 |
SIGNATORY'S PHONE NUMBER | 202-408-4000 |
SIGNATURE METHOD | Sent to third party for signature |
FILING INFORMATION | |
SUBMIT DATE | Thu May 06 11:45:06 ET 2021 |
TEAS STAMP | USPTO/ESU-XX.XXX.X.X-2021 0506114506516787-88821077 -780a824aafb7bb328e50cb1d a4cf68fe9bc4bf13468990a90 25b78dc0118f35d4-CC-45030 326-20210506103208460127 |
PTO- 1581 |
Approved for use through 03/31/2024. OMB 0651-0054 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |